SEB (ENXTPA:SK) has just posted its H1 2026 scorecard, with total revenue at about €8.2b on a trailing 12 month basis and Basic EPS at €2.84. Half year snapshots for 2025 show revenue between roughly €3.7b and €4.4b and EPS ranging from €0.01 to €8.28. Over recent half year periods, the company recorded revenue of €4,525.8m in H2 2024, €3,747.7m in H1 2025, and €4,421.7m in H2 2025, while Basic EPS moved from €2.41 to €0.01 and then €8.28. This creates a mixed backdrop with a clear focus on earnings for the latest release. Margins are in the spotlight here as investors assess how efficiently SEB is turning this revenue base into profit quality.
See our full analysis for SEB.With the headline figures on the table, the next step is to compare these results with the widely held market narratives about SEB to see which stories align with the numbers and which start to look stretched.
See what the community is saying about SEB
Bulls point to SEB’s product pipeline and Asia footprint as reasons recent margin gains may only be the starting point, and they map that story out in far more detail in the 🐂 SEB Bull Case
Skeptics argue that SEB’s cash coverage and leverage leave little room for error if growth slows, and you can see how they build that argument in the 🐻 SEB Bear Case
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for SEB on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If this mix of SEB optimism and concern leaves you uncertain, take the time to review the numbers yourself and weigh up the 4 key rewards and 2 important warning signs
SEB’s mixed picture of modest 3% net margins, slower revenue growth than the French reference, and stretched cash coverage against sizeable debt highlights meaningful balance sheet pressure.
If those leverage concerns make you cautious, compare SEB with companies that have stronger financial cushions by scanning the solid balance sheet and fundamentals stocks screener (421 results) today and see which businesses better match your risk comfort.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com